News for Plus Therapeutics, Inc. (PSTV)

HOUSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. ( PSTV) (the ”œCompany”), a clinical-stage pharmaceutical company developing targeted r

Plus Therapeutics (PSTV) achieved a 75% clinical benefit rate through neuroimaging in its Phase 1 ReSPECT-LM trial for REYOBIQâ„¢. No dose-limiting toxi

Summary: Plus Therapeutics (PSTV) is offering 1.57 billion shares to current stockholders. Analysts provide a positive outlook with potential upside exce

Cash and Investments Balance: $3.6 million as of December 31, 2024, compared to $8.6 million at December 31, 2023.Grant Revenue: $5.8 million in 2024, up from

Mar 27, 2025 / 09:00PM GMTOperator Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics fourth quarter and full-year 2024 results conference call.

Plus Therapeutics' Q4 2024 earnings reveal progress with REYOBIQ nearing FDA approval & CNSide's 2025 launch. Key hires & funding bolster milestones.

Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ETCompany ParticipantsMarc Hedrick - President and CEOAndrew...

The recent $15 million financing accelerates development of REYOBIQâ„¢ and launch of CNSideâ„¢ HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics

Plus (PSTV) delivered earnings and revenue surprises of -31.37% and 6.49%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

New Jersey-based Greenland Acquisition Corp (GTEC) is up over 79 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

March 11, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including bio...

Shares of Ouster, Inc. OUST rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results. Ouster...

**media[570655]**

We recently published a list of 10 Best Short-Term Stocks To Buy Right Now. In this article, we are going to take a look at where CervoMed Inc.

HOUSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. ( PSTV) (the ”œCompany” or ”œPlus Therapeutics”), a clinical-stage pharmaceutical co

We recently published an article titled Micro-, Small-Cap Firms Dominate Market Rally. In this article, we are going to take a look at where Plus Therapeutics, Inc.

Plus Therapeutics stock rises after peer-reviewed publication of Phase 1 glioma data and FDA Orphan Drug Designation for lung cancer treatment.

Texas-based Intuitive Machines, Inc. (LUNR) is down over 35 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Rhenium (186Re) Obisbemeda demonstrates safety, response, and potential efficacy for glioblastoma (GBM) patients Patients receiving >100 Gy of Rhenium (186Re)